Matrix metalloproteinase inhibition counteracts impairment of cortical experience-dependent plasticity after

A Cybulska-Klosowicz1, M Liguz-Lecznar, D Nowicka

  • 1Department of Molecular and Cellular Neurobiology, Nencki Institute, 3 Pasteur Street, 02-093 Warsaw, Poland.

Insights

Inhibiting matrix metalloproteinases (MMPs) after a stroke helps restore brain plasticity. This study shows MMP inhibition rescues use-dependent plasticity in the barrel cortex following photothrombotic stroke.

Area of Science:

  • Neuroscience
  • Neuroplasticity
  • Stroke Research

Background:

  • Matrix metalloproteinases (MMPs) influence brain plasticity and stroke pathophysiology.
  • MMP inhibition post-stroke can reduce infarct size and improve recovery.
  • Previous research indicated photothrombotic stroke impairs use-dependent plasticity.

Purpose of the Study:

  • To investigate if MMP inhibition can restore plastic capacity in the barrel cortex after photothrombotic stroke.
  • To determine the role of MMPs in the disruption of use-dependent plasticity near ischemic lesions.

Main Methods:

  • Adult mice underwent photothrombotic stroke near the barrel cortex.
  • Unilateral vibrissae deprivation (row C spared) was used to induce plasticity.
  • Mice received a broad-spectrum MMP inhibitor (FN-439) or vehicle.
  • Functional cortical representation was mapped using [(14)C]2-deoxyglucose uptake.

Main Results:

  • Vibrissae deprivation failed to induce plasticity in stroke-affected mice.
  • MMP inhibition with FN-439 prior to stroke restored plasticity, evidenced by enlarged cortical representation of spared vibrissae.
  • Control (non-stroke) animals showed expected plasticity changes.

Conclusions:

  • Matrix metalloproteinases (MMPs) play a critical role in impairing use-dependent plasticity after ischemic lesions.
  • Inhibiting MMPs presents a potential therapeutic strategy to preserve or restore brain plasticity post-stroke.

Related Concept Videos